Strong dose-response using a conjunctival provocation test during a phase II allergen immunotherapy study with subcutaneously administered tyrosine adsorbed modified grass allergen + MPL

Authors
Category Primary study
ConferenceAllergy: European Journal of Allergy and Clinical Immunology
Year 2019
This article has no abstract
Epistemonikos ID: 911dcc58273e1b9684988d0603f5a439c7c13a82
First added on: Apr 29, 2026